The Validity and Reliability of the Turkish Version of the BBAQ
Launched by ISTANBUL MEDENIYET UNIVERSITY · May 11, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on a tool called the Barriers to Being Active Quiz (BBAQ), which helps identify challenges people face in staying physically active. The goal of this study is to translate the quiz into Turkish and ensure that it works well in that language and culture. By doing this, researchers hope to make the quiz useful for Turkish speakers who want to understand and overcome barriers to being active.
To participate in this study, you need to be at least 18 years old and able to read and write in Turkish. It's important that you do not have any serious health conditions that could limit your ability to be active, such as certain types of arthritis or neurological issues. If you decide to take part, you will be asked to complete the translated quiz, which will help researchers improve the support available for people looking to increase their physical activity levels. The study is not yet recruiting participants, so more information will be available soon.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 years or older
- • Ability to read and write in Turkish
- • No visual or hearing impairments that would interfere with participation
- • Ability to follow simple instructions
- • Willingness to participate in the study
- Exclusion Criteria:
- • Diagnosis of rheumatological conditions that may limit physical activity and are characterized by chronic inflammation and/or joint deformities (e.g., rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, psoriatic arthritis)
- • Physical limitations due to neurological or orthopedic conditions (e.g., stroke, cerebral palsy, multiple sclerosis, limb amputation, or orthopedic surgery within the past six months)
- • History of psychiatric disorders that may impair cognitive functioning (e.g., schizophrenia, bipolar disorder, severe depression, attention deficit hyperactivity disorder)
- • Presence of any cognitive impairment
About Istanbul Medeniyet University
Istanbul Medeniyet University is a prominent academic institution based in Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct innovative studies aimed at improving healthcare outcomes. With a strong emphasis on ethical standards and scientific rigor, Istanbul Medeniyet University collaborates with healthcare professionals and researchers to explore new therapeutic strategies and contribute to the global body of medical knowledge. Their commitment to fostering a research-driven environment facilitates the development of cutting-edge treatments and enhances patient care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kartal, İstanbul, Turkey
Maltepe, İstanbul, Turkey
Kartal, , Turkey
Maltepe, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported